Key takeaways:
You can safely take GLP-1 medications if you have high cholesterol.
GLP-1 medications can modestly lower LDL (“bad”) cholesterol and total cholesterol.
GLP-1s aren’t approved to treat high cholesterol and shouldn’t replace medications like statins. But improvement in cholesterol levels may be an added benefit if you’re taking GLP-1s for another condition.
Save on related medications
Glucagon-like peptide-1 (GLP-1) agonists have quickly become some of the most talked-about medications ever developed. There are several FDA-approved GLP-1 agonists including:
Semaglutide (Ozempic, Wegovy, Ryelsus)
Liraglutide (Victoza, Saxenda)
Dulaglutide (Trulicity)
Tirzepatide (Mounjaro, Zepbound)
Orforglipron (Foundayo)
Exenatide (Byetta, Bydureon BCise)
GLP-1 medications are best known for their role in treating conditions like Type 2 diabetes and obesity. But their effects go beyond blood sugar and weight. They also influence heart health in important ways.
High cholesterol is a common condition that can increase your risk of heart attack and stroke over time. Many people with high cholesterol wonder whether GLP-1 medications can help improve their cholesterol levels.
In this article, we’ll look at whether it’s safe to take GLP-1 medications if you have high cholesterol, and how they may affect cholesterol levels and heart health.
Is it safe to take GLP-1s with high cholesterol?
Yes, it’s safe to take GLP-1 medications if you have high cholesterol.
None of the FDA-approved GLP-1 medications list dyslipidemia as a contraindication. This means that GLP-1s can be used safely in people with a wide range of cholesterol conditions.
This includes people with cholesterol conditions that run in families like:
Familial hypercholesterolemia (high LDL or “bad” cholesterol)
Familial hypertriglyceridemia (high triglycerides)
People who develop high cholesterol later in life can also safely take GLP-1 medications. This includes people who develop high cholesterol from medications, lifestyle factors, or other health conditions.
GLP-1 medications are also considered safe across different types of cholesterol problems, including:
High LDL cholesterol (hypercholesterolemia)
High triglycerides (hypertriglyceridemia)
Low HDL cholesterol (“good” cholesterol)
Mixed dyslipidemia (where several cholesterol levels are affected)
Do GLP-1s lower cholesterol?
Yes, GLP-1s can lower cholesterol, but they don’t affect all types of fats in your blood the same way. Cholesterol is made up of several different types of fats in your blood. These include:
LDL (“bad” cholesterol), which can build up in arteries
HDL (“good” cholesterol), which helps remove cholesterol from the bloodstream
Triglycerides, another type of fat linked to heart disease when levels are high
Studies show that GLP-1 medications can lower LDL or “bad” cholesterol by a few points and reduce total cholesterol, too. They may also lower triglycerides, especially after eating. Some GLP-1 medications may slightly increase levels of HDL or “good” cholesterol. Overall, the effects on triglycerides and HDL cholesterol aren’t as consistent as effects on LDL and total cholesterol levels.
These changes were once thought to be related to the weight loss that people can experience while taking these medications. But research suggests there’s more going on. GLP-1s may affect how the body processes fats. For example, they can reduce the amount of fat released into the bloodstream after meals and help the body clear certain cholesterol particles more efficiently.
What is the best GLP-1 medication for high cholesterol?
There isn’t a “best” GLP-1 medication for high cholesterol. These medications aren’t FDA approved to treat high cholesterol or any type of dyslipidemia.
They’re also not a replacement for standard treatments for high cholesterol, like statin therapy. And they can’t replace treatments that lower triglyceride levels. These therapies have been specifically studied for cholesterol management. There’s strong evidence showing they are safe and work for most people.
Right now, there aren’t any studies showing that GLP-1 medications can also safely treat high cholesterol. So we don’t know how well they would work for most people, what the right dosage would be, or how long people would need to take them.
For now, GLP-1 medications should be used for their approved indications. If your cholesterol improves while taking a GLP-1, that’s a helpful extra benefit.
Does insurance cover GLP-1s for high cholesterol?
Insurance will not cover GLP-1 medications to treat high cholesterol.
Commercial insurance and Medicare may cover GLP-1 medications when they’re used to treat conditions that have received FDA approval. This includes conditions like Type 2 diabetes and obstructive sleep apnea in certain people. GLP-1 medications are also FDA approved for weight management and to lower the risk of heart and kidney disease in certain people.
Who shouldn’t take GLP-1s for high cholesterol?
GLP-1 medications aren’t right for everyone. You may not be able to take a GLP-1 medication if you have:
A personal or family history of medullary thyroid cancer
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
A history of anaphylaxis (serious allergic reaction) to GLP-1 medications
A history of pancreatitis or gastric paresis
You shouldn’t take GLP-1s if you are pregnant or nursing.
Frequently asked questions
Yes, cardiologists can prescribe GLP-1 medications. Any prescriber can prescribe a GLP-1 medication. Special licensing or training isn’t required.
High cholesterol can develop for several different reasons. For many people, it’s linked to how the body processes fats and sugars, which can be influenced by conditions like Type 2 diabetes and obesity.
Diet, physical activity, and smoking can affect levels of “good” and “bad” cholesterol over time.
Treatment for high cholesterol includes diet changes and increasing physical activity. Medications such as statins can also help lower cholesterol levels. Your healthcare team can help you choose the best approach based on your overall health.
Yes, cardiologists can prescribe GLP-1 medications. Any prescriber can prescribe a GLP-1 medication. Special licensing or training isn’t required.
High cholesterol can develop for several different reasons. For many people, it’s linked to how the body processes fats and sugars, which can be influenced by conditions like Type 2 diabetes and obesity.
Diet, physical activity, and smoking can affect levels of “good” and “bad” cholesterol over time.
Treatment for high cholesterol includes diet changes and increasing physical activity. Medications such as statins can also help lower cholesterol levels. Your healthcare team can help you choose the best approach based on your overall health.
The bottom line
You can take a GLP-1 medication if you have high cholesterol. There’s evidence that GLP-1 medications can modestly improve cholesterol levels. But GLP-1 medications aren’t a substitute for standard cholesterol-lowering therapies.
GLP-1 medications haven’t been studied as a treatment for high cholesterol and aren’t FDA approved for dyslipidemias. If you’re already taking a GLP-1 for another approved use, you may also see some added benefit in your cholesterol levels.
Why trust our experts?
References
American Heart Association. (2026). What causes high cholesterol?
Berberich, A. J., et al. (2021). Lipid effects of glucagon-like peptide 1 receptor analogs. Current Opinion in Lipidology.
Berro Rivera, F., et al. (2025). Glucagon-like peptide 1 receptor agonists modestly reduced low-density lipoprotein cholesterol and total cholesterol levels independent of weight reduction: a meta-analysis and meta-regression of placebo controlled randomized controlled trials. Current Medical Research and Opinion.
Cho, Y. K., et al. (2023). The cardiovascular effect of tirzepatide: A glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide dual agonist. Journal of Lipid and Atherosclerosis.
Matikainen, N., et al. (2018). Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized controlled study. Diabetes, Obesity and Metabolism.
Newman, J. D., et al. (2018). The changing landscape of diabetes therapy for cardiovascular risk reduction: JACC state-of-the-art review. Journal of the American College of Cardiology.
Pappan, N., et al. (2024). Dyslipidemia. StatPearls.
Vergès, B., et al. (2021). Liraglutide increases the catabolism of apolipoprotein B100-containing lipoproteins in patients with Type 2 diabetes and reduces proprotein convertase subtilisin/kexin Type 9 expression. Diabetes Care.
